Jubilant Pharmova (Previously Jubilant Life Sciences)

I think Ingrevia is undervalued as per pees of same sector. Trading at roughly 4100 Crs market cap with expected EPS of 18 gives a PE calculation of 15. I have added to my position received from demerger.
Also, created a separate topic for Ingrevia discussion here